146 related articles for article (PubMed ID: 18271548)
1. Mathematical modeling of corticosteroid pharmacogenomics in rat muscle following acute and chronic methylprednisolone dosing.
Yao Z; Hoffman EP; Ghimbovschi S; Dubois DC; Almon RR; Jusko WJ
Mol Pharm; 2008; 5(2):328-39. PubMed ID: 18271548
[TBL] [Abstract][Full Text] [Related]
2. Microarray analysis of the temporal response of skeletal muscle to methylprednisolone: comparative analysis of two dosing regimens.
Almon RR; DuBois DC; Yao Z; Hoffman EP; Ghimbovschi S; Jusko WJ
Physiol Genomics; 2007 Aug; 30(3):282-99. PubMed ID: 17473217
[TBL] [Abstract][Full Text] [Related]
3. A microarray analysis of the temporal response of liver to methylprednisolone: a comparative analysis of two dosing regimens.
Almon RR; DuBois DC; Jusko WJ
Endocrinology; 2007 May; 148(5):2209-25. PubMed ID: 17303664
[TBL] [Abstract][Full Text] [Related]
4. Fifth-generation model for corticosteroid pharmacodynamics: application to steady-state receptor down-regulation and enzyme induction patterns during seven-day continuous infusion of methylprednisolone in rats.
Ramakrishnan R; DuBois DC; Almon RR; Pyszczynski NA; Jusko WJ
J Pharmacokinet Pharmacodyn; 2002 Feb; 29(1):1-24. PubMed ID: 12194533
[TBL] [Abstract][Full Text] [Related]
5. Modeling of corticosteroid pharmacogenomics in rat liver using gene microarrays.
Jin JY; Almon RR; DuBois DC; Jusko WJ
J Pharmacol Exp Ther; 2003 Oct; 307(1):93-109. PubMed ID: 12808002
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomic responses of rat liver to methylprednisolone: an approach to mining a rich microarray time series.
Almon RR; Dubois DC; Jin JY; Jusko WJ
AAPS J; 2005 Aug; 7(1):E156-94. PubMed ID: 16146338
[TBL] [Abstract][Full Text] [Related]
7. Meta-modeling of methylprednisolone effects on glucose regulation in rats.
Fang J; Sukumaran S; Dubois DC; Almon RR; Jusko WJ
PLoS One; 2013; 8(12):e81679. PubMed ID: 24312573
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamic/pharmacogenomic modeling of insulin resistance genes in rat muscle after methylprednisolone treatment: exploring regulatory signaling cascades.
Yao Z; Hoffman EP; Ghimbovschi S; DuBois DC; Almon RR; Jusko WJ
Gene Regul Syst Bio; 2008 Apr; 2():141-61. PubMed ID: 19787081
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamics and pharmacogenomics of diverse receptor-mediated effects of methylprednisolone in rats using microarray analysis.
Almon RR; DuBois DC; Brandenburg EH; Shi W; Zhang S; Straubinger RM; Jusko WJ
J Pharmacokinet Pharmacodyn; 2002 Apr; 29(2):103-29. PubMed ID: 12361239
[TBL] [Abstract][Full Text] [Related]
10. Application of scaling factors in simultaneous modeling of microarray data from diverse chips.
Yao Z; Zhao B; Hoffman EP; Ghimbovschi S; DuBois DC; Almon RR; Jusko WJ
Pharm Res; 2007 Apr; 24(4):643-9. PubMed ID: 17318415
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic Multi-Tissue Modeling of Glucocorticoid-Induced Leucine Zipper Regulation: Integrating Circadian Gene Expression with Receptor-Mediated Corticosteroid Pharmacodynamics.
Ayyar VS; DuBois DC; Almon RR; Jusko WJ
J Pharmacol Exp Ther; 2017 Oct; 363(1):45-57. PubMed ID: 28729456
[TBL] [Abstract][Full Text] [Related]
12. The genomic response of skeletal muscle to methylprednisolone using microarrays: tailoring data mining to the structure of the pharmacogenomic time series.
Almon RR; DuBois DC; Piel WH; Jusko WJ
Pharmacogenomics; 2004 Jul; 5(5):525-52. PubMed ID: 15212590
[TBL] [Abstract][Full Text] [Related]
13. Temporal profiling of the transcriptional basis for the development of corticosteroid-induced insulin resistance in rat muscle.
Almon RR; Dubois DC; Jin JY; Jusko WJ
J Endocrinol; 2005 Jan; 184(1):219-32. PubMed ID: 15642798
[TBL] [Abstract][Full Text] [Related]
14. Corticosteroid-regulated genes in rat kidney: mining time series array data.
Almon RR; Lai W; DuBois DC; Jusko WJ
Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E870-82. PubMed ID: 15985454
[TBL] [Abstract][Full Text] [Related]
15. Functional proteomic analysis of corticosteroid pharmacodynamics in rat liver: Relationship to hepatic stress, signaling, energy regulation, and drug metabolism.
Ayyar VS; Almon RR; DuBois DC; Sukumaran S; Qu J; Jusko WJ
J Proteomics; 2017 May; 160():84-105. PubMed ID: 28315483
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamics of glucose regulation by methylprednisolone. I. Adrenalectomized rats.
Jin JY; Jusko WJ
Biopharm Drug Dispos; 2009 Jan; 30(1):21-34. PubMed ID: 19156931
[TBL] [Abstract][Full Text] [Related]
17. Gene arrays and temporal patterns of drug response: corticosteroid effects on rat liver.
Almon RR; DuBois DC; Pearson KE; Stephan DA; Jusko WJ
Funct Integr Genomics; 2003 Dec; 3(4):171-9. PubMed ID: 12928814
[TBL] [Abstract][Full Text] [Related]
18. Modeling Corticosteroid Pharmacokinetics and Pharmacodynamics, Part II: Sex Differences in Methylprednisolone Pharmacokinetics and Corticosterone Suppression.
Ayyar VS; DuBois DC; Nakamura T; Almon RR; Jusko WJ
J Pharmacol Exp Ther; 2019 Aug; 370(2):327-336. PubMed ID: 31197019
[TBL] [Abstract][Full Text] [Related]
19. Receptor/gene/protein-mediated signaling connects methylprednisolone exposure to metabolic and immune-related pharmacodynamic actions in liver.
Ayyar VS; Sukumaran S; DuBois DC; Almon RR; Qu J; Jusko WJ
J Pharmacokinet Pharmacodyn; 2018 Aug; 45(4):557-575. PubMed ID: 29704219
[TBL] [Abstract][Full Text] [Related]
20. Fourth-generation model for corticosteroid pharmacodynamics: a model for methylprednisolone effects on receptor/gene-mediated glucocorticoid receptor down-regulation and tyrosine aminotransferase induction in rat liver.
Sun YN; DuBois DC; Almon RR; Jusko WJ
J Pharmacokinet Biopharm; 1998 Jun; 26(3):289-317. PubMed ID: 10098101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
